1,400 prisoners in Massachusetts have gotten the coronavirus vaccine, and officials are holding vaccine education programs to encourage more to do the same. Kathryn Stephenson, MD, MPH (Center for Virology and Vaccine Research, BIDMC) is among those working on getting more information to prisoners to address their concerns.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke about how the COVID-19 pandemic has unfolded globally, the Johnson & Johnson vaccine candidate, and new virus strains.
President Biden’s goal of 100 million shots in 100 days may be hindered by the lack of vaccine doses. Public health officials are eagerly awaiting late-stage trial results for the one-dose vaccine candidate developed by Johnson & Johnson in collaboration with BIDMC.
Experts welcomed Moderna’s announcement that the company’s vaccine would protect people against variants of the virus that recently emerged in Britain and South Africa but concerns about the vaccine being less effective against the South Africa variant remain. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) was more cautious in his assessment of the announcement from Moderna and noted it’s premature to read too much into the study.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke with CNN Chief Medical Correspondent Dr. Sanjay Gupta for CNN’s Coronavirus Fact vs. Fiction podcast about how the Johnson & Johnson vaccine is different from other COVID-19 vaccines that are currently available, and how soon it could reach Americans.
Boston Marathon Race Director Dave McGillivray, who owns DMSE sports, has been tapped to be the overall operations manager for the state's mass vaccination sites at Gillette Stadium and Fenway Park. DMSE Sports is working with the Baker administration, BIDMC, and others to make the mass vaccination sites a reality.
